The North America L-Carnitine Market would witness market growth of 4.22% CAGR during the forecast period (2019-2025).
Increased health concerns among the geriatric population, together with growing customer inclination towards preventive healthcare, are anticipated to drive growth in the market throughout the forecast period. L-carnitine is known to improve the recovery of elderly people following exercise. It also helps to reduce fatigue and enhance the functioning of the mind. It also minimizes the likelihood of a decline in the skeleton, which is widespread among the aging population. The product helps to maintain lean muscle mass, reduce muscle degradation, and promote healthy aging.
The product is also used to help people with low natural L-carnitine levels. Deficiency can occur due to several factors like genetic disorders, drug use, and medical conditions such as skeletal myopathies. These factors increased the demand for L-carnitine as dietary supplements exclusively.
Feed grade is commonly used in animal feed and animal pharmaceuticals as the main ingredient. It is an important component of animal energy metabolism and provides a wide range of benefits to different species, like weight management and healthy heart and liver function. It is also mainly used as a supplement for pets with heart problems, particularly in dogs with dilated cardiomyopathy. This is also used as an important supplement to combat obesity, hyperlipidemia, and diabetic ketoacidosis, usually found in cats and dogs. The product is a preferred option to treat fatty liver syndrome in cats.
Based on Product, the market is segmented into Food & Pharma Grade and Feed Grade. Based on Process, the market is segmented into Chemical Synthesis and Bioprocess. Based on Application, the market is segmented into Healthcare Product, Functional Drink, Medicine and Animal Food. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Lonza Group AG, Northeast Pharmaceutical Group Co. Ltd., Cayman Chemical Company, Inc., Tokyo Chemical Industry Co. Ltd., Ceva Sante Animale S.A., Kaiyuan Hengtai Chemical Co., Ltd., ChengDa Pharmaceuticals Co., Ltd., HuangGang HuaYang Pharmaceutical Co., Ltd., and HuBei YuanCheng SaiChuang Technology Co. Ltd.
Scope of the Study
- Food & Pharma Grade
- Feed Grade
- Chemical Synthesis
- Healthcare Product
- Functional Drink
- Animal Food
- Rest of North America
- Merck Group
- Lonza Group AG
- Northeast Pharmaceutical Group Co. Ltd.
- Cayman Chemical Company, Inc.
- Tokyo Chemical Industry Co. Ltd.
- Ceva Sante Animale S.A.
- Kaiyuan Hengtai Chemical Co., Ltd.
- ChengDa Pharmaceuticals Co., Ltd.
- HuangGang HuaYang Pharmaceutical Co., Ltd.
- HuBei YuanCheng SaiChuang Technology Co. Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free